Click on image to view larger version.

Figure 3 (A) Kaplan-Meier analysis for 9-month major adverse cardiac event (MACE)-free survivals in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) and in those with stable angina. (B) Kaplan-Meier analysis for survivals free from 9-month ischemia-driven target lesion revascularization (TLR) in NSTEACS patients and in those with stable angina.